Terms: = Bone cancer AND MYD88, Q99836, MYD88D, 4615 AND Treatment
51 results:
1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
2. Multiple Genomic Alterations, Including a Novel
Sahin Y; Wang YL; Pei J; Mansoor N; Styler M; Testa JR; Nejati R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203475
[TBL] [Abstract] [Full Text] [Related]
3. Challenging diagnosis of IgM multiple myeloma.
Mahmood F; Ahmed B; Thalody V; Mehdi S
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38176750
[TBL] [Abstract] [Full Text] [Related]
4. miR-199a-3p suppresses neuroinflammation by directly targeting myd88 in a mouse model of bone cancer pain.
Saadh MJ; Rashed AB; Jamal A; Castillo-Acobo RY; Kamal MA; Cotrina-Aliaga JC; Gonzáles JLA; Alothaim AS; Alhoqail WA; Ahmad F; Lakshmaiya N; Amin AH; Younus DG; Rojas GGR; Bahrami A; Akhavan-Sigari R
Life Sci; 2023 Nov; 333():122139. PubMed ID: 37783266
[TBL] [Abstract] [Full Text] [Related]
5. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
Treon SP; Tedeschi A; San-Miguel J; Garcia-Sanz R; Anderson KC; Kimby E; Minnema MC; Benevolo G; Qiu L; Yi S; Terpos E; Tam CS; Castillo JJ; Morel P; Dimopoulos M; Owen RG
Semin Hematol; 2023 Mar; 60(2):97-106. PubMed ID: 37173155
[TBL] [Abstract] [Full Text] [Related]
6. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
[TBL] [Abstract] [Full Text] [Related]
7. treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Talaulikar D; Joshua D; Ho PJ; Gibson J; Quach H; Gibbs S; Ling S; Ward C; Augustson BM; Trotman J; Harrison SJ; Tam CS;
Intern Med J; 2023 Apr; 53(4):599-609. PubMed ID: 36441109
[TBL] [Abstract] [Full Text] [Related]
8. The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia.
Szelest M; Masternak M; Zając M; Chojnacki M; Skórka K; Zaleska J; Karczmarczyk A; Stasiak G; Wawrzyniak E; Kotkowska A; Siemieniuk-Ryś M; Purkot J; Subocz E; Cichocka E; Tomczak W; Zawirska D; Giannopoulos K
PLoS One; 2022; 17(10):e0276674. PubMed ID: 36282861
[TBL] [Abstract] [Full Text] [Related]
9. [Waldenström disease: News and perspectives in 2022].
Bouclet F; Krzisch D; Leblond V; Tomowiak C; Laribi K; Ysebaert L; Tournilhac O; Dartigeas C; Leprêtre S; Jondreville L;
Bull Cancer; 2023 Jan; 110(1):88-100. PubMed ID: 36229266
[TBL] [Abstract] [Full Text] [Related]
10. IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function.
Li S; Yao JC; Oetjen KA; Krambs JR; Xia J; Zhang J; Schmidt AP; Helton NM; Fulton RS; Heath SE; Turnbull IR; Mbalaviele G; Ley TJ; Walter MJ; Link DC
Blood; 2022 Oct; 140(14):1607-1620. PubMed ID: 35675516
[TBL] [Abstract] [Full Text] [Related]
11. SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia.
Sermer D; Sarosiek S; Branagan AR; Treon SP; Castillo JJ
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):547-556. PubMed ID: 35339405
[TBL] [Abstract] [Full Text] [Related]
12. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION.
Salman AR; Ferenchak K; Olsen TW; Smith WM; Ketterling RP; McPhail ED; Salomao DR; Dalvin LA
Retin Cases Brief Rep; 2023 Sep; 17(5):572-576. PubMed ID: 37490925
[TBL] [Abstract] [Full Text] [Related]
13. SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.
Thomas SK
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):347-355. PubMed ID: 34980578
[TBL] [Abstract] [Full Text] [Related]
14. Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
Treon SP; Meid K; Hunter ZR; Flynn CA; Sarosiek SR; Leventoff CR; White TP; Cao Y; Roccaro AM; Sacco A; Demos MG; Guerrera ML; Kofides A; Liu X; Xu L; Patterson CJ; Munshi M; Tsakmaklis N; Yang G; Ghobrial IM; Branagan AR; Castillo JJ
Blood; 2021 Oct; 138(17):1535-1539. PubMed ID: 34289017
[TBL] [Abstract] [Full Text] [Related]
15. Clinical application of genomics in Waldenström macroglobulinemia.
Branagan AR; Lei M; Treon SP; Castillo JJ
Leuk Lymphoma; 2021 Aug; 62(8):1805-1815. PubMed ID: 33569985
[TBL] [Abstract] [Full Text] [Related]
16. Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressing gastric cancer model.
Bali P; Lozano-Pope I; Pachow C; Obonyo M
Int J Oncol; 2021 Mar; 58(3):388-396. PubMed ID: 33469673
[TBL] [Abstract] [Full Text] [Related]
17. Management of Waldenström macroglobulinemia in 2020.
Castillo JJ; Treon SP
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):372-379. PubMed ID: 33275726
[TBL] [Abstract] [Full Text] [Related]
18. CXCR4 in Waldenström's Macroglobulinema: chances and challenges.
Kaiser LM; Hunter ZR; Treon SP; Buske C
Leukemia; 2021 Feb; 35(2):333-345. PubMed ID: 33273682
[TBL] [Abstract] [Full Text] [Related]
19. Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia.
Treon SP; Meid K; Gustine J; Yang G; Xu L; Liu X; Patterson CJ; Hunter ZR; Branagan AR; Laubach JP; Ghobrial IM; Palomba ML; Advani R; Castillo JJ
J Clin Oncol; 2021 Feb; 39(6):565-575. PubMed ID: 32931398
[TBL] [Abstract] [Full Text] [Related]
20. On point in primary CNS lymphoma.
Tsang M; Cleveland J; Rubenstein JL
Hematol Oncol; 2020 Dec; 38(5):640-647. PubMed ID: 32510610
[TBL] [Abstract] [Full Text] [Related]
[Next]
